{"transactions":[{"id":782242,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-12T20:30:13.000Z","date":"2026-05-09","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 9, 2026; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":22000,"derivative":{"exercise_price":1.58,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001434099-26-000002","document":"form4-05122026_040506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000143409926000002/form4-05122026_040506.xml","form_type":"4"}},{"id":959519,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T23:20:06.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":72464,"price":1.38,"value":100000.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split."}],"balance_after":95181,"source":{"system":"sec-edgar","filing":"0001434099-25-000004","document":"form4-12232025_061203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000143409925000004/form4-12232025_061203.xml","form_type":"4"}},{"id":1152137,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-12T20:15:13.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":63150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 8, 2025; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":63150,"derivative":{"exercise_price":0.17,"expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":63150},"source":{"system":"sec-edgar","filing":"0001415889-25-012650","document":"form4-05122025_040509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012650/form4-05122025_040509.xml","form_type":"4"}},{"id":1156102,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":false,"shares":81967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.1844,"expiration_date":"2025-05-02","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1156101,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and\nexpiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and\nexpiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":0.1844,"expiration_date":"2025-05-02","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1156100,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and\nexpiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and\nexpiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1156099,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants (right to buy)","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":false,"shares":81967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.1844,"expiration_date":"2025-05-02","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1156098,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants (right to buy)","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":0.1844,"expiration_date":"2025-05-02","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1156097,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants (right to buy)","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.45,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1156096,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":81967,"price":0.1844,"value":15114.7148,"ownership":{"direct":true},"balance_after":681538,"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1156095,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-08T00:45:05.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":81967,"price":0.1844,"value":15114.7148,"ownership":{"direct":true},"balance_after":599571,"source":{"system":"sec-edgar","filing":"0001415889-25-012286","document":"form4-05072025_080501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588925012286/form4-05072025_080501.xml","form_type":"4"}},{"id":1322759,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:15:16.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":49490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date."}],"balance_after":49490,"derivative":{"exercise_price":0.24,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":49490},"source":{"system":"sec-edgar","filing":"0001415889-24-030061","document":"form4-12232024_041213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588924030061/form4-12232024_041213.xml","form_type":"4"}},{"id":1389226,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Warrants (right to buy)","published_at":"2024-10-08T20:15:08.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":253164,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 253,164 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 253,164 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":253164,"derivative":{"exercise_price":0.27,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":253164},"source":{"system":"sec-edgar","filing":"0001415889-24-024867","document":"form4-10082024_041004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588924024867/form4-10082024_041004.xml","form_type":"4"}},{"id":1389225,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants (right to buy)","published_at":"2024-10-08T20:15:08.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":0.45,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-24-024867","document":"form4-10082024_041004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588924024867/form4-10082024_041004.xml","form_type":"4"}},{"id":1389224,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants (right to buy)","published_at":"2024-10-08T20:15:08.000Z","date":"2024-10-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-24-024867","document":"form4-10082024_041004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588924024867/form4-10082024_041004.xml","form_type":"4"}},{"id":1389223,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-08T20:15:08.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":253164,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 253,164 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 253,164 shares of common stock."}],"balance_after":517604,"source":{"system":"sec-edgar","filing":"0001415889-24-024867","document":"form4-10082024_041004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588924024867/form4-10082024_041004.xml","form_type":"4"}},{"id":1478864,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T21:00:09.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to\nthe Reporting Person continuing to provide service through each such date."}],"balance_after":33650,"derivative":{"exercise_price":1.47,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":33650},"source":{"system":"sec-edgar","filing":"0001415889-24-016965","document":"form4-06142024_050605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000141588924016965/form4-06142024_050605.xml","form_type":"4"}},{"id":1709127,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2023-12-15T13:18:28.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001209191-23-058713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919123058713/doc4.xml","form_type":"4"}},{"id":1709126,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A  Warrants (right to buy)","published_at":"2023-12-15T13:18:28.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001209191-23-058713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919123058713/doc4.xml","form_type":"4"}},{"id":1709125,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T13:18:28.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."}],"balance_after":264440,"source":{"system":"sec-edgar","filing":"0001209191-23-058713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919123058713/doc4.xml","form_type":"4"}},{"id":1851945,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T23:47:11.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 15, 2023 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":85000,"derivative":{"exercise_price":2.12,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-23-038124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919123038124/doc4.xml","form_type":"4"}},{"id":2151940,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-23T21:05:13.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person."}],"balance_after":13500,"derivative":{"exercise_price":2.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-22-051159","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919122051159/doc4a.xml","form_type":"4/A","original_submission_date":"2022-06-14"}},{"id":2179451,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-18T20:07:27.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":105263,"price":1.9,"value":199999.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 77,210 shares received as an annual annuity payment from the Reporting Person's GRAT.  This transfer constitutes a mere change in the form of ownership and is exempt from reporting pursuant to Rule 16a-13."}],"balance_after":182473,"source":{"system":"sec-edgar","filing":"0001209191-22-046598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919122046598/doc4.xml","form_type":"4"}},{"id":2232535,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-14T23:07:27.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":10500,"derivative":{"exercise_price":2.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-036807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919122036807/doc4.xml","form_type":"4"}},{"id":2619882,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-03T01:23:58.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on August 29, 2021 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":10500,"derivative":{"exercise_price":10,"expiration_date":"2031-07-29","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-049151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000120919121049151/doc4.xml","form_type":"4"}},{"id":3497079,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T20:15:42.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":3537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3537,"derivative":{"exercise_price":5.23,"exercise_date":"2020-06-06","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":3537},"source":{"system":"sec-edgar","filing":"0001140361-19-010671","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000114036119010671/form4.xml","form_type":"4"}},{"id":3880429,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:40:08.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":39742,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39742,"derivative":{"exercise_price":1.46,"exercise_date":"2019-06-28","expiration_date":"2028-06-28","underlying":"Common Stock","underlying_shares":39742},"source":{"system":"sec-edgar","filing":"0001140361-18-030732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000114036118030732/form4.xml","form_type":"4"}},{"id":4353435,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":47946,"kind":"person","name":"Brandt Peter C.","position":1,"cik":"0001434099","reported_name":"Brandt Peter C.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-04-12T21:21:08.000Z","date":"2017-04-11","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":110000,"derivative":{"exercise_price":0.618,"exercise_date":"2018-04-11","expiration_date":"2027-04-11","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001140361-17-015706","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434099/000114036117015706/form4.xml","form_type":"4"}}]}